Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.
Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S. Kutcher S, et al. Among authors: huss m. Eur Neuropsychopharmacol. 2004 Jan;14(1):11-28. doi: 10.1016/s0924-977x(03)00045-2. Eur Neuropsychopharmacol. 2004. PMID: 14659983 Review.
Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder.
Greenhill L, Beyer DH, Finkleson J, Shaffer D, Biederman J, Conners CK, Gillberg C, Huss M, Jensen P, Kennedy JL, Klein R, Rapoport J, Sagvolden T, Spencer T, Swanson JM, Volkow N. Greenhill L, et al. Among authors: huss m. J Atten Disord. 2002;6 Suppl 1:S89-100. doi: 10.1177/070674370200601s11. J Atten Disord. 2002. PMID: 12685523 Review.
Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients.
Findling RL, Robb AS, DelBello M, Huss M, McNamara N, Sarkis E, Scheffer R, Poulsen LH, Chen G, Lemming OM, Areberg J, Auby P. Findling RL, et al. Among authors: huss m. J Child Adolesc Psychopharmacol. 2017 Aug;27(6):526-534. doi: 10.1089/cap.2016.0155. Epub 2017 Mar 23. J Child Adolesc Psychopharmacol. 2017. PMID: 28333546 Free PMC article. Clinical Trial.
Childhood methylphenidate treatment of ADHD and response to affective stimuli.
Schlochtermeier L, Stoy M, Schlagenhauf F, Wrase J, Park SQ, Friedel E, Huss M, Lehmkuhl U, Heinz A, Ströhle A. Schlochtermeier L, et al. Among authors: huss m. Eur Neuropsychopharmacol. 2011 Aug;21(8):646-54. doi: 10.1016/j.euroneuro.2010.05.001. Epub 2010 May 31. Eur Neuropsychopharmacol. 2011. PMID: 20570115
Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.
Hervas A, Huss M, Johnson M, McNicholas F, van Stralen J, Sreckovic S, Lyne A, Bloomfield R, Sikirica V, Robertson B. Hervas A, et al. Among authors: huss m. Eur Neuropsychopharmacol. 2014 Dec;24(12):1861-72. doi: 10.1016/j.euroneuro.2014.09.014. Epub 2014 Oct 23. Eur Neuropsychopharmacol. 2014. PMID: 25453486 Free article. Clinical Trial.
A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders.
Findling RL, Robb AS, DelBello MP, Huss M, McNamara NK, Sarkis EH, Scheffer RE, Poulsen LH, Chen G, Lemming OM, Auby P. Findling RL, et al. Among authors: huss m. J Child Adolesc Psychopharmacol. 2018 Feb;28(1):47-54. doi: 10.1089/cap.2017.0047. Epub 2017 Oct 16. J Child Adolesc Psychopharmacol. 2018. PMID: 29035574 Free PMC article. Clinical Trial.
296 results